[ad_1]
Ukrainian doctors will be the first to receive a free coronavirus vaccine, Ukraine’s Health Minister Maxim Stepanov said.
Ukraine’s Minister of Health Maxim Stepanov, on his Facebook page, told how free vaccines against COVID-19 will be distributed in the country.
According to him, on November 19 an online conference was held with representatives of COVAX (an initiative for global access to vaccines against COVID-19), during which an additional action plan for the supply of a future vaccine was determined. to Ukraine.
The minister stressed that the priority of the first stage of vaccination is health workers.
Ukraine will receive the vaccine in several installments. The first will be about 1.2 million doses. In total, COVAX plans to provide Ukraine with around 8 million doses of coronavirus vaccine.
As Stepanov pointed out, this will allow to vaccinate up to 20% of Ukrainian citizens for free.
“Our next steps in cooperation with COVAX are the signing of a Ukraine technical need and the terms of cooperation,” said the minister.
An outbreak of coronavirus infection began in late 2019 in China. March 11, 2020 World Health Organization declared the spread of the coronavirus a pandemic.
The World Health Organization believes that Ukraine to receive COVID-19 vaccine as part of COVAX in the second quarter of 2021.
By information World Health Organization As of November 3, there are 47 COVID-19 vaccine manufacturers worldwide that are candidates for clinical evaluation of the produced vaccine. 155 companies are conducting preclinical trials.
The American company Pfizer announced on November 9 that its COVID-19 BNT162b2 vaccine, developed in conjunction with the German BioNTech, has shown an efficacy of more than 90% in the third phase of clinical trials. The director of the World Health Organization, Tedros Adhanom Ghebreyesus, called the vaccine “very promising.” Pfizer has already sold about 82% of its vaccine doses. The company continues to investigate BNT162b2.
Another American biotech company, Moderna, announced on November 16 that the second phase of its clinical trials was successfully completed in mid-July. 45 people between 18 and 55 years old attended. The third and final phase of testing for mRNA-1273 began on July 27. This vaccine has shown an efficacy of 94.5%. The company plans to produce 20 million doses by the end of 2020 for shipment to the United States and 500 million to 1 billion doses in 2021 for sale in other countries.
ABOUT registration of “the world’s first vaccine” of coronavirus infection – “Sputnik V” (“Gam-COVID-Vac”) – said Russian President Vladimir Putin on August 11. But it did not pass the third stage of clinical trials. In the United States, it is considered unfinished. Cases of COVID-19 are known among those vaccinated with this drug.
